Umbralisib and Carfilzomib Potently Inhibit Cap Dependent Translation in Lymphoma

Hematological Oncology - United Kingdom
doi 10.1002/hon.193_2631
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Umbralisib: Treatment for a Rare Lymphoma?

Cancer Discovery
Oncology
2019English

The Cap-Dependent Translation Apparatus Integrates and Amplifies Cancer Pathways

RNA Biology
Cell BiologyMolecular Biology
2006English

A Cyclin-Dependent Kinase, CDK11/p58, Represses Cap-Dependent Translation During Mitosis

Cellular and Molecular Life Sciences
Molecular NeuroscienceMolecular MedicineCell BiologyMolecular BiologyPharmacologyCellular
2020English

Reovirus-Induced Modification of Cap-Dependent Translation in Infected L Cells.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1980English

Cap-Translation Inhibitor, 4egi-1, Restores Sensitivity to ABT-737 Apoptosis Through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia

Clinical Cancer Research
Cancer ResearchOncology
2013English

A Novel Role of 4e-Bp, the Repressor of Cap-Dependent Translation, in Oastoarthrithis

Osteoarthritis and Cartilage
Sports MedicineRheumatologyOrthopedicsBiomedical Engineering
2016English

Proteomic Analysis of Cap-Dependent Translation Identifies LARP1 as a Key Regulator of 5'TOP mRNA Translation

Genes and Development
GeneticsDevelopmental Biology
2014English

Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival and Metastasis of Hepatocellular Carcinoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Fully Human Antagonistic Antibodies Against CCR4 Potently Inhibit Cell Signaling and Chemotaxis

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy